EPIGENETIC MODIFICATION OF SOCS-1 DIFFERENTIALLY REGULATES STAT3 ACTIVATION IN RESPONSE TO INTERLEUKIN-6 RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING THROUGH JAK AND/OR MEK IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS

LEE, T.L., YEH, J., & VAN WAES, C.. (2006). EPIGENETIC MODIFICATION OF SOCS-1 DIFFERENTIALLY REGULATES STAT3 ACTIVATION IN RESPONSE TO INTERLEUKIN-6 RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING THROUGH JAK AND/OR MEK IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS. MOLECULAR CANCER THERAPEUTICS, 5(1), 8-19. SID. https://sid.ir/paper/624054/en

LEE T.L., YEH J., VAN WAES C.. EPIGENETIC MODIFICATION OF SOCS-1 DIFFERENTIALLY REGULATES STAT3 ACTIVATION IN RESPONSE TO INTERLEUKIN-6 RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING THROUGH JAK AND/OR MEK IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS. MOLECULAR CANCER THERAPEUTICS[Internet]. 2006;5(1):8-19. Available from: https://sid.ir/paper/624054/en

T.L. LEE, J. YEH, and C. VAN WAES, “EPIGENETIC MODIFICATION OF SOCS-1 DIFFERENTIALLY REGULATES STAT3 ACTIVATION IN RESPONSE TO INTERLEUKIN-6 RECEPTOR AND EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING THROUGH JAK AND/OR MEK IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS,” MOLECULAR CANCER THERAPEUTICS, vol. 5, no. 1, pp. 8–19, 2006, [Online]. Available: https://sid.ir/paper/624054/en